These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 9033970

  • 1. GAD 65 antibody but not ICA positivity in adult-onset diabetic patients is associated with early progression to clinical insulin dependency.
    Hatziagelaki E, Jaeger C, Maeser E, Bretzel RG, Federlin K.
    Acta Diabetol; 1996 Dec; 33(4):291-4. PubMed ID: 9033970
    [Abstract] [Full Text] [Related]

  • 2. Islet cell antibodies and antibodies against glutamic acid decarboxylase in newly diagnosed adult-onset diabetes mellitus.
    Willis JA, Scott RS, Brown LJ, Forbes LV, Schmidli RS, Zimmet PZ, MacKay IR, Rowley MJ.
    Diabetes Res Clin Pract; 1996 Jul; 33(2):89-97. PubMed ID: 8879963
    [Abstract] [Full Text] [Related]

  • 3. UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group.
    Turner R, Stratton I, Horton V, Manley S, Zimmet P, Mackay IR, Shattock M, Bottazzo GF, Holman R.
    Lancet; 1997 Nov 01; 350(9087):1288-93. PubMed ID: 9357409
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Latent autoimmune diabetes mellitus in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency.
    Zimmet PZ, Tuomi T, Mackay IR, Rowley MJ, Knowles W, Cohen M, Lang DA.
    Diabet Med; 1994 Apr 01; 11(3):299-303. PubMed ID: 8033530
    [Abstract] [Full Text] [Related]

  • 6. Clinical characteristics of patients with the initial diagnosis of NIDDM with positivity for antibodies to glutamic acid decarboxylase.
    Inukai T, Fujiwara Y, Tayama K, Aso Y, Ogino K, Takemura Y.
    Exp Clin Endocrinol Diabetes; 1997 Apr 01; 105(6):327-30. PubMed ID: 9439927
    [Abstract] [Full Text] [Related]

  • 7. Autoantibodies associated with presymptomatic insulin-dependent diabetes mellitus in women.
    Whittingham S, Byron SL, Tuomilehto J, Zimmet PZ, Myers MA, Vidgren G, Rowley MJ, Feeney SJ, Koskela P, Tuomilehto-Wolf E, Mackay IR.
    Diabet Med; 1997 Aug 01; 14(8):678-85. PubMed ID: 9272595
    [Abstract] [Full Text] [Related]

  • 8. Combined analysis of islet cell antibodies that cross-react with mouse pancreas, antibodies to the M(r) 64,000 islet protein, and antibodies to glutamate decarboxylase in type I diabetic patients.
    Chaillous L, Delamaire M, Martignat L, Maugendre D, Marre M, Mathieu E, Limal JM, Charbonnel B, Allannic H, Saï P.
    Diabetes Care; 1994 Oct 01; 17(10):1115-23. PubMed ID: 7821130
    [Abstract] [Full Text] [Related]

  • 9. [Detection of antibodies against pancreatic islet cells in clinical practice].
    Pánczél P, Külkey O, Luczay A, Bornemisza B, Illyés G, Halmos T, Baranyi E, Blatniczky L, Mészáros J, Kerényi Z, Geró L, Tamás G, Hosszúfalusi N, Horváth L, Madácsy L, Romics L.
    Orv Hetil; 1999 Nov 28; 140(48):2695-701. PubMed ID: 10645715
    [Abstract] [Full Text] [Related]

  • 10. The combination of antibodies to GAD-65 and IA-2ic can replace the islet-cell antibody assay to identify subjects at risk of type 1 diabetes mellitus.
    Hatziagelaki E, Jaeger C, Petzoldt R, Seissler J, Scherbaum WA, Federlin K, Bretzel RG.
    Horm Metab Res; 1999 Oct 28; 31(10):564-9. PubMed ID: 10596966
    [Abstract] [Full Text] [Related]

  • 11. GAD antibodies in NIDDM. Ten-year follow-up from the diagnosis.
    Niskanen LK, Tuomi T, Karjalainen J, Groop LC, Uusitupa MI.
    Diabetes Care; 1995 Dec 28; 18(12):1557-65. PubMed ID: 8722051
    [Abstract] [Full Text] [Related]

  • 12. GAD antibodies seldom disappear in slowly progressive IDDM.
    Kobayashi T, Nakanishi K, Okubo M, Murase T, Kosaka K.
    Diabetes Care; 1996 Sep 28; 19(9):1031. PubMed ID: 8875105
    [No Abstract] [Full Text] [Related]

  • 13. Heterogeneity in the occurrence of a subset of autoantibodies to glutamic acid decarboxylase in autoimmune polyendocrine patients with islet cell antibodies.
    Davenport C, Radford PM, Al-Bukhari TA, Lai M, Bottazzo GF, Todd I.
    Clin Exp Immunol; 1998 Mar 28; 111(3):497-505. PubMed ID: 9528889
    [Abstract] [Full Text] [Related]

  • 14. Type 1 diabetes in insulin-treated adult-onset diabetic subjects.
    Willis J, Scott R, Brown L, Zimmet P, MacKay I, Rowley M.
    Diabetes Res Clin Pract; 1998 Oct 28; 42(1):49-53. PubMed ID: 9884033
    [Abstract] [Full Text] [Related]

  • 15. Prevalence and clinical characteristics of insulin-treated, anti-GAD-positive, type 2 diabetic subjects in an outpatient clinical department of a Dutch teaching hospital.
    Römkens TE, Kusters GC, Netea MG, Netten PM.
    Neth J Med; 2006 Apr 28; 64(4):114-8. PubMed ID: 16609158
    [Abstract] [Full Text] [Related]

  • 16. Tyrosine phosphatase-related islet antigen 2(256-760) autoantibodies, the only marker of islet autoimmunity that increases by increasing the degree of BMI in obese subjects with type 2 diabetes.
    Buzzetti R, Spoletini M, Zampetti S, Campagna G, Marandola L, Panimolle F, Dotta F, Tiberti C, NIRAD Study Group (NIRAD 8).
    Diabetes Care; 2015 Mar 28; 38(3):513-20. PubMed ID: 25567348
    [Abstract] [Full Text] [Related]

  • 17. Small doses of subcutaneous insulin as a strategy for preventing slowly progressive beta-cell failure in islet cell antibody-positive patients with clinical features of NIDDM.
    Kobayashi T, Nakanishi K, Murase T, Kosaka K.
    Diabetes; 1996 May 28; 45(5):622-6. PubMed ID: 8621013
    [Abstract] [Full Text] [Related]

  • 18. Immune abnormalities in diabetic patients not requiring insulin at diagnosis.
    Di Mario U, Irvine WJ, Borsey DQ, Kyner JL, Weston J, Galfo C.
    Diabetologia; 1983 Nov 28; 25(5):392-5. PubMed ID: 6360778
    [Abstract] [Full Text] [Related]

  • 19. Correlation of islet cell antibodies and HLA-DR phenotypes with diabetes mellitus in adults.
    Gleichmann H, Zörcher B, Greulich B, Gries FA, Henrichs HR, Betrams J, Kolb H.
    Diabetologia; 1984 Jul 28; 27 Suppl():90-2. PubMed ID: 6383926
    [Abstract] [Full Text] [Related]

  • 20. Autoantibodies to glutamic acid decarboxylase and insulin in islet cell antibody positive presymptomatic type 1 diabetes mellitus: frequency and segregation by age and gender.
    Zimmet PZ, Elliott RB, Mackay IR, Tuomi T, Rowley MJ, Pilcher CC, Knowles WJ.
    Diabet Med; 1994 Nov 28; 11(9):866-71. PubMed ID: 7705024
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.